Clinical Trials Browser

Not yet recruiting × Breast Neoplasms × Taxes × Clear all

NCT06632405 2025-03-26

A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC

Phase 2 Not yet recruiting

Breast Neoplasms